During melanoma progression, E-cadherins are progressively reduced to allow for the dissociation between melanocytes and keratinocytes followed by concomitant upregulation of N-cadherins to support melanoma cell survival, and migration through tissues, a process regulated by the PI3K/AKT pathway (54–56). This evidence concerns the gene CDH1 and melanoma.